SafetyLit Journal Details

We are unable to provide photocopies of any the articles and reports abstracted in SafetyLit updates. Where possible, links have been provided to the publisher of the material and contact information for the corresponding author is listed. Please consider asking your library to subscribe to the journals from which these abstracts have been gathered.

To recommend a journal for this list please: Send SafetyLit an Email Message

Signal transduction and targeted therapy

Abbreviation: Signal Transduct. Target Ther.

Published by: Holtzbrinck Springer-Nature

Publisher Location: London, England, UK

Journal Website:
http://www.nature.com/sigtrans/

Alt: URL:
https://www.ncbi.nlm.nih.gov/pmc/journals/3308/

Range of citations in the SafetyLit database: 2024; 9(1) -- 2024; 9(1)

Publication Date Range: 2016 --

Number of articles from this journal included in the SafetyLit database: 1
(Download all articles from this journal in CSV format.)

pISSN = 2095-9907 | eISSN = 2059-3635
LCCN = 2016243461 | USNLM = 101676423 | OCLC = 958669440

Find a library that holds this journal: http://worldcat.org/issn/20959907

Journal Language(s): English

Aims and Scope (from publisher): Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is an open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, such as cancer, autoimmune disorders and others.

Articles in database by volume, issue.